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The malaria parasite Plasmodium invades a host erythrocyte, multiplies within
a parasitophorous vacuole (PV) and then ruptures the PV and erythrocyte
membranes in a process known as egress. Both egress and invasion are controlled by effector proteins discharged from specialized secretory organelles.
The aspartic protease plasmepsin X (PM X) regulates activity for many of these
effectors, but it is unclear how PM X accesses its diverse substrates that reside
in different organelles. PM X also autoprocesses to generate different isoforms. The function of this processing is not understood. We have mapped the
self-cleavage sites and have constructed parasites with cleavage site mutations. Surprisingly, a quadruple mutant that remains full-length retains in vitro
activity, is trafﬁcked normally, and supports normal egress, invasion and
parasite growth. The N-terminal half of the prodomain stays bound to the
catalytic domain even after processing and is required for proper intracellular
trafﬁcking of PM X. We ﬁnd that this enzyme cleaves microneme and exoneme
substrates before discharge, while the rhoptry substrates that are dependent
on PM X activity are cleaved after exoneme discharge into the PV. The data give
insight into the temporal, spatial and biochemical control of this unusual but
important aspartic protease.

Malaria is caused by the parasitic protozoan Plasmodium and accounts
for more than 600,000 deaths annually1. The majority of deaths are
due to infection with Plasmodium falciparum. The disease symptoms
result exclusively from the blood stage of infection during which the
parasite replicates asexually within the host red blood cells (RBCs) by a
process termed schizogony. Each schizont matures into 8–32 merozoites and, by rupturing the parasitophorous vacuolar membrane
(PVM) surrounding the parasite as well as the red blood cell membrane
(RBCM), exits from the host cells by a process called “egress”2.
The egressed merozoites subsequently invade fresh RBCs. Given the
importance of the intraerythrocytic cycles of egress and invasion in the
spread of the infection, it is, therefore, of considerable interest to target
these processes for the development of disease intervention strategies.
The Plasmodium aspartic protease plasmepsin X (PM X) is
essential for replication of P. falciparum during the intraerythrocytic

cycle3–5. In mature schizonts, PM X is located in the exoneme secretory
organelle and is involved in the proteolytic activation of the other
exoneme-localized protease subtilisin-like protease 1 (SUB1). Upon
release into the parasitophorous vacuole (PV), SUB1 encounters and
activates downstream effectors such as serine repeat antigens (SERAs)
and the merozoite surface proteins (MSPs)6–8. Concerted activities of
these molecules lead to rupture of both the PVM and the RBCM,
releasing the daughter parasites into the bloodstream. Importantly,
PM X is druggable, as multiple classes of compounds targeting PM X
have high efﬁcacies both in vitro and in vivo as well as being active on
different life stages3–5.
Recent data based on PM X inhibitors and peptide substrate
cleavage analysis, suggest that aside from SUB1, PM X has additional
substrates in other secretory organelles that function during parasite
invasion5. Among these substrates, the apical membrane antigen1
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(AMA1), subtilisin 2 (SUB2) and the erythrocyte binding antigens
(EBAs) are targeted to the micronemes9,10, whereas the reticulocyte
binding protein homologs (Rhs) are trafﬁcked to the rhoptries11. These
substrates are therefore spatially segregated from PM X in mature
schizonts. How and where PM X gains access to these proteins for
processing is a mystery.
The primary Pfpm x gene product (p64) consists of an N-terminal
prodomain (PD) followed by a catalytic domain4,12. This precursor PM X
is converted into multiple shorter forms (p52, p49 and p42) through
autoproteolytic cleavage5. The processing of PM X never goes to
completion, as both unprocessed and processed forms are detected in
terminal schizonts3. However, the signiﬁcance of this partial processing remains unknown. Recent data demonstrate a PM X-speciﬁc
inhibitor can bind to multiple processed forms of PM X, suggesting
that they may be active5.
In this work, we sought to address the following important
question: how does the processing regulate PM X trafﬁcking, activity,
and substrate speciﬁcity, given the multiple processed forms of PM X
and the differentially localized substrate repertoire? We ﬁnd that PM X
has unusual characteristics for an aspartic protease and provide cellular evidence to explain its ability to process substrates in different
compartments.

Results
PM X undergoes autocleavage at multiple sites that are independent of each other
Previously we reported that multiple processed and unprocessed
forms of PM X remain in terminal schizonts3. To shed light on the
signiﬁcance of PM X processing, it was of interest to determine the
cleavage sites. However, because of low abundance of PM X in parasites, we were unable to extract enough native enzyme from parasite
lysates for N-terminal sequence analysis. We therefore took advantage
of the recombinant PM X (rPM X) that we could successfully express as
a C-terminally 8x-histidine-tagged secreted protein in mammalian
cells. The protein was a mixture of differentially processed polypeptides (Fig. 1a, b). Of these, one polypeptide of ~12 kDa molecular weight
(p12) was detected only in the Coomassie blot but not in the western
blot with an anti-His antibody, suggesting that it is an N-terminal
fragment (red line and red arrow in Fig. 1a, b). To precisely determine
the composition of p12, we excised the band from the gel and subjected it to proteomic analysis (Supplementary Data 1). This conﬁrmed
that p12 represents the cleaved N-terminal fragment from the PD of
rPM X (Fig. 1a, red arrow). Immunoprecipitation with anti-HA antibody
could pull down the differentially processed His-tagged polypeptides
from an N-terminally HA tagged version of rPM X (Supplementary
Fig. 1). This suggests that p12 stays bound to each of the processed
forms. Among the higher molecular weight fragments that retained the
C-terminal 8x-His tag, we were able to determine the sequence of the
42 kDa polypeptide (p42) by LC/MS (Fig.1 a, b, light blue arrows;
Supplementary Data 2). Importantly, the N-terminus of this polypeptide ended at a nontryptic leucine residue (open arrow end on light
blue line in Fig. 1a).
The amino acid sequence (IALE) that spans the N-terminal end of
p42 conforms to the PM X substrate cleavage speciﬁcity deﬁned by
Favuzza et al.5. To test this further, we mutated the last two residues to
alanine (IALE to IAAA, Supplementary Fig. 2). Such di-mutation had
been shown to abolish cleavage of a ﬂuorogenic peptide by isolated
PM X4,5. This mutated version of PM X (rIAAA) expressed in mammalian
cells, exhibited processing indistinguishable from that of wild type
(Fig. 1c). 7 amino acids upstream of this cleavage site is another
sequence motif (SSIE) that corresponds to the PM X peptide cleavage
speciﬁcity (Fig. 1a, Supplementary Fig. 2). While mutation of this
alternate site alone (SSIE to SSAA) had no effect, mutation of both sites
together (rSS/IADbl mut) prevented processing to p42 (Fig. 1c, d).
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Importantly, the rSS/IADbl mut still underwent normal cleavage at an
upstream site, as shown by the presence of p12 in the Coomassie blot
(Fig. 1d, left panel).
The p12 fragment (red arrows in Fig. 1a, b) ended at a nontryptic
phenylalanine at the C terminus (Supplementary Data 1). To see if this
fragment results from autoproteolytic cleavage, we mutated the amino
acid sequence spanning the C terminal end (NFLD to NFAA, Supplementary Fig. 2). The resultant mutant (rNFAA) was still cleaved,
although differently from that of the WT (Fig. 1c, d, gray arrow). LC/ MS
conﬁrmed that this fragment was cleaved after an aspartate, which is
20 amino acids downstream from that of the WT derived fragment
(Supplementary Data 3, gray arrow in Fig. 1a). The sequence ﬂanking
this new C terminal end (SDIQ) also conformed to the PM X substrate
cleavage speciﬁcity. Simultaneous mutations of all four identiﬁed sites
(rQuadmut, Supplementary Fig. 2) completely blocked the processing of
rPM X, resulting into the accumulation of the full-length form (Fig. 1c,
d, right panels).
To further analyze these cleavages, we moved to cultured parasites and expressed PM X mutants as GFP-tagged second copies. For
WT, we observed four bands (90, 77, 75 and 68 kDa, corresponding to
the GFP fusions to p64, p52, p49 and p42, respectively). Mutation of
NFLD and SDIQ together abolished processing to the 77 and 75 kDa but
not to the 68 kDa form (Fig. 1e). Mutation of IALE and SSIE together
blocked processing to the 68 kDa form, but had no impact on processing to the 77 or 75 kDa forms. Finally, a quadruple mutant
(Quadmut) resulted in accumulation of the full-length form. The data
suggest that similar to the mammalian rPM X, PM X expressed in
parasites undergoes autocatalytic processing at multiple sites that are
independent of each other.

Proteolytic processing is not necessary for parasite growth or
for activity of PM X
Our second copy mutants were made in an endogenous PM X TetRregulated knockdown line, PM Xapt (see ref. 3). Wild-type second copy
PM X but not a catalytically dead mutant (D266G) can rescue the
growth defect that is seen when parasites are grown in the absence of
anhydrotetracycline (aTc) to deplete endogenous PM X (see ref. 3 and
Supplementary Fig. 3). Surprisingly, each of the cleavage site mutants
including the quadruple mutant (Quadmut) was able to rescue growth in
the absence of aTc (Fig. 2a). We analyzed the processing of PM X
substrate proteins SUB1 and AMA1 by the different cleavage mutant
forms of PM X when endogenous PM X was knocked down. As previously reported3, withdrawal of aTc in the parental PM Xapt line results
in a processing defect in conversion of the SUB1 54 kDa intermediate to
the mature 47 kDa form (Fig. 2b). This PM X knockdown also impairs
conversion of the AMA1 70 kDa precursor to the 60 kDa form. Processing of both proteins was fully restored by second copy expression
of the different PM X cleavage mutants.
The observation that even the quadruple mutant could efﬁciently
cleave SUB1 and fully restore parasite growth in the absence of
endogenous PM X was of particular interest. To assess the enzyme
activity of the second copy PM X, we pulled down WT and Quadmut PM
X from parasites using anti-GFP antibodies followed by in vitro substrate cleavage assays (Fig. 3 and Supplementary Fig. 4). As a control,
we similarly pulled down the active site D266G PM X mutant from
parasites. The Quadmut PM X showed robust substrate cleavage activity
comparable to that of the WT at pH 5.5 (Fig. 3). For both samples the
activity dropped at pH 6.5 though there was a difference in residual
activity between the Quadmut and the WT enzyme. At pH 7.5, both
samples lost their activity. As expected, the PM X inhibitor, CWHM-117
was able to block activity for both samples and the D266G did
not show signiﬁcant activity even at pH 5.5. Together, these data
suggest that processing of PM X is not important for its function in
parasites.
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In vitro activity of rPM X is correlated with acid-induced structural changes
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For many proteases, the N-terminal prodomain (PD) remains tightly
bound to the catalytic domain, acting as an endogenous inhibitor
for the mature enzyme13,14. Removal of the PD is therefore necessary
for enzyme activation. Surprisingly we noticed that the N-terminal
fragment of the proenzyme remains noncovalently attached to the
processed rPM X after isolation (Fig. 1b). To understand this, we
carried out size-exclusion chromatography on WT rPM X that had
been pre-incubated in different pH conditions (pH 7.5 and 5.5).
Upon gel ﬁltration under acidic conditions, rPM X eluted in a single
peak that is identical to the one obtained at pH 7.5 (Fig. 4a, top
panel, Supplementary Fig. 5). In contrast, hemoglobin tetramers,
which dissociate to monomers under acidic conditions15, demonstrated a shift in the elution proﬁle at pH 5.5 (Fig. 4a, bottom panel).

For PM X an additional peak that corresponds to p12 was observed
when a denaturing agent, guanidine hydrochloride (GuHCl) was
added in the acidic medium (Fig. 4b, c). The p12 polypeptide
remained associated with the main peak at pH 5.5 without denaturant (Fig. 4c) and was evenly distributed throughout the peak by
SDS-PAGE and by dynamic light scattering (Supplementary Fig. 5).
Together these data suggest that the activation of PM X does not
involve complete removal of the N-terminal part of the PD. Consistent with this, the rQuadmut PM X demonstrated robust substrate
cleavage activity in acidic buffer (Supplementary Fig. 6). To further
investigate PM X’s dependency on acidic pH for activation, we
examined the WT rPM X by circular dichroism (CD) spectroscopy.
As indicated by changes in molar ellipticity, a signiﬁcant decrease
was observed in the alpha helical composition of rPM X at pH 5.5 as
compared to pH 7.5 (Fig. 4d and Supplementary Table 1).

Fig. 1 | Autoprocessing sites are conserved between the heterologously
expressed and parasite PM X. a Schematic of the likely identities of the different
processed forms of C-terminally 8x His tagged PM X (rPM X) expressed from the
HEK293 cells. Predicted mass of the polypeptides based on their amino acid
compositions are indicated. Thick lines indicate the processed fragments that were
detected either by western blot or by Coomassie blot. Orange thin lines represent
processed bands not detected. Amino acid sequence ﬂanking the PM X autocleavage sites are indicated with positional information. Green dotted arrows
represent the scissile bonds. PD prodomain, CAT catalytic domain. The red, blue
and gray arrows represent the peptide coverage regions obtained from LC/MS.
Filled arrow heads: tryptic ends, empty arrow heads: nontryptic ends. Colors correspond to the bands highlighted by same color arrows in b and d. Additional
mutated constructs used in this study are depicted in Supplementary Fig. 1. b Left,

anti-His immunoblot; right, Coomassie stain of wild type rPM X (rWT). Anti-His
immunoblot (c) and Coomassie gel (d) showing processing of rWT or mutant rPM X
at multiple autocleavage sites. rSS/IADbl mut : SSAA/IAAA double mutant; rQuadmut :
quadruple mutant with additional NFAA and SDAA mutations. e Expression of
second-copy PM X in parasites. Left, schematic of the second copy PM X that was
introduced into parasites as a C-terminally GFP-tagged construct. Labels as in a.
Right, top panel: anti-GFP immunoblot, the assigned unprocessed and differentially
processed forms indicated by color coded lines. Bottom panel: lysates from the
same samples but blotted with anti-PM V antibody as loading control. NF/SDDbl mut :
NFAA/SDAA double mutant; SS/IADbl mut : SSAA/IAAA double mutant; Quadmut :
quadruple mutant with all four cleavage sites changed to AA in the P1’ and P2’
positions. Each experiment (b–e) was repeated at least three times and shown are
representative blots. Source data are provided as a Source Data ﬁle.
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Fig. 3 | Proteolytic processing is not necessary for in vitro activity of PM X.
Second copy PM X-GFP was puriﬁed from synchronized 42–45 h schizonts using
anti-GFP antibody. The pulled down proteins were then incubated with ﬂuorogenic
Rh2N substrate peptide (1 μM) at the indicated pH. In control wells, CWHM-117
(1 μM) was added to inhibit PM X activity. Reactions were carried out for 1 h at 37 °C.
Mean values from three independent experiments are shown and error bars
represent standard deviations. Data were analyzed statistically by two-tailed Student’s t test, p values are shown on the graph. Source data are provided as a Source
Data ﬁle.
Fig. 2 | Autocatalytic processing of PM X is not required for parasite replication
and substrate cleavage. a The parental PM Xapt parasites or PM Xapt parasites
expressing the indicated PM X as a second copy were grown either in the presence
or absence of aTc for 96 h. The starting parasitemia was 1% across different samples. Shown are the ﬁnal parasitemia percentages after 2 erythrocytic cycles, normalized to that of the PM Xapt parasites grown in the presence of aTc for 96 h. Mean
values from three independent experiments are shown and error bars represent
standard deviations. Data were analyzed statistically by two-tailed Student’s t test.
***p = 0.00002. b The parasite lines from a were MACS synchronized for 3 h and
were grown for the next 45 h either in the presence or absence of aTc. Parasites
were then harvested and whole cell lysates were prepared. Western blots were
performed to detect the expression of the second copy PM X-GFP (top panel),
endogenous PM X-FLAG (second panel), AMA1 (third panel) and SUB1 (bottom
panel). On the right is the PM Xapt line without second-copy PM X expression. The
antibodies used and the speciﬁc molecular weights of the different processed
forms of proteins are indicated. This experiment was repeated two times and
shown is a representative blot. Source data are provided as a Source Data ﬁle.

The N-terminal PD piece is required for intracellular trafﬁcking
and functionality of PM X
To see how the PD regulates PM X function, we made truncation
mutations in the PD and expressed the truncated PM X as
C-terminally GFP-tagged second copies in a SUB1-3xHA parasite
line (Fig. 5a). Speciﬁcally, we either deleted the sequence between
the N-terminal signal peptide (SP) and the NFLD autocleavage site
(delA) or the sequence between the NFLD and the downstream
IALE cleavage site (delB). As a control, we made a third construct
that lacked the entire PD (delPD). IFAs with mature schizonts
showed that, similar to the WT PM X, the delB but not the delA or
delPD was substantially colocalized with the SUB1-3xHA in exonemes (Fig. 5b, c, Supplementary Fig. 7). We believe that partial
cleavage of GFP from the PM X during secretion (Fig. 1e) accounts
for the imperfect colocalization of WT and delB PM X with SUB1.
The delA and delPD, on the other hand, showed near complete
colocalization with the ER resident protease PM V16–18. To further
assess intracellular trafﬁcking by an orthologous measure, we
looked at the secretion of second copy PM X into the culture
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supernatant from synchronized 41–44 h schizonts that were pretreated with zaprinast. Zaprinast is a phosphodiesterase (PDE)
inhibitor and causes premature egress of parasites by promoting
discharge of effectors from apical secretory organelles in a protein
kinase G (PKG)-dependent manner19. Western blots from fractionated samples showed that, similar to the endogenous PM X (antiFLAG blot), both the WT and delB but not delA (anti-GFP blot) were
partially secreted into the culture supernatant following a 45 min
zaprinast treatment (Fig. 5d). Together with the IFAs, this data
therefore suggests that the N-terminal part of the PD carries
information that is critical for folding and trafﬁcking of PM X
beyond the ER.
In addition to trafﬁcking, we also looked at the growth of the
transgenic lines that were made in the PM Xapt background. As shown in
Fig. 5e, in the absence of aTc, the growth defect observed in the parental line could be restored in the WT or delB but not the delAexpressing parasite lines. We pulled down the different second copy
PM X versions from parasite lines using anti-GFP antibodies and tested
their activities on ﬂuorogenic peptide. As shown in supplementary
Fig. 8, the delB but not the delA PM X was active at pH 5.5. Therefore,
the N-terminal fragment of the PD appears to be critical for PM X
activity, likely by aiding correct folding of the protease.

Autocatalytic processing of PM X occurs in a late secretory
compartment
To understand the maturation of PM X further, we treated synchronized 40–43 h parasites expressing PM X-3xHA for 8 h with the
cysteine protease inhibitor E64d to prevent egress but still allow
organellar discharge as well as PVM rupture and RBCM poration20,21.
Secreted proteins (supernatants) were then separated from those that
remained intercellular by centrifugation. As shown in Fig. 6, similar to
the vehicle (DMSO)-treated samples, both unprocessed and processed
forms of PM X were detected in the culture supernatant of the E64dtreated samples. As expected, treatment with the protein kinase G
(PKG) inhibitor compound 1 (C1), which blocks apical organellar
4
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Fig. 4 | The p12 polypeptide remains attached to rPM X under activation
conditions. a Overlay of the elution proﬁles of WT rPM X (top) or hemoglobin a
(bottom) following size exclusion chromatography at the indicated pH. b Elution
proﬁle of rPM X following size exclusion chromatography at pH 5.5 in the absence
(top) or presence (bottom) of 6 M guanidine HCl (GuHCl) as a denaturant. Samples
were pretreated in the same buffer before loading onto the column. Numbers

within dotted lines indicate the fractions that were collected to run on SDS-PAGE
followed by Coomassie staining (c). Subfractionation analysis of the pH 5.5 peak is
shown in Supplementary Fig 5. d Comparison of the molar ellipticity of WT rPM X
preincubated at the indicated pH and analyzed by circular dichroism spectroscopy.
Experiment was repeated three times in triplicate. Shown are the mean values from
one representative experiment. Source data are provided as a Source Data ﬁle.

discharge in P. falciparum, blocked the secretion of PM X into the
culture supernatant19. Importantly, the fungal metabolite brefeldin A
(BFA), which prevents transport of newly synthesized secretory proteins out of the ER22,23, completely blocked PM X processing (Supplementary Fig. 9). This indicates that all the processing steps happen in a
post-ER compartment.

detect the presence of the processed 50 kDa form when parasites were
allowed to discharge the apical organellar contents. As expected, all
three proteins were accumulated in their precursor forms when samples were cultured in absence of aTc to knock down PM X. Finally, as a
control for organellar discharge, we analyzed the PV-localized
SUB1 substrate SERA5. Processing of its 126 kDa precursor to lower
molecular weight forms was detected only when activated SUB1 was
discharged into the PV (+aTc/+ E64d sample). Additionally, AMA1 was
found to be correctly localized in terminal schizonts even in the
absence of aTc, suggesting that the PM X-mediated cleavage is not
necessary for trafﬁcking to the micronemes (Supplementary Fig. 10).
Altogether, the data suggest cleavage of different substrates by PM X is
regulated spatially in P. falciparum.
Importantly, the fact that PM X could cleave the micronemelocalized substrate AMA1 in the presence of C1 suggested that the two
proteins encounter each other intracellularly before organellar discharge. To further understand how PM X interacts with non-exoneme
proteins, we carried out high resolution 3D-confocal Airyscan microscopy with C1-treated terminal schizonts expressing PM X-3xHA or
SUB1-3xHA. In cells that were dual-labeled with anti-AMA1 and anti-HA
antibodies, we observed differences in the punctate patterns of
expression of AMA1 compared to PM X or SUB1, but there were regions
that showed complete overlap between the protein pairs (Fig. 8a, b, 2D
and 3D snapshots respectively). This is of particular interest since an
earlier study reported that AMA1 and SUB1 are targeted to different

PM X cleaves microneme and rhoptry substrate at different
cellular locations
The processing defect of the micronemal protein AMA1 seen upon
knockdown of PM X (Fig. 2b) provides a genetic conﬁrmation for the
previously observed inhibition of AMA1 cleavage by a PM X-speciﬁc
inhibitor4,5. The same work also identiﬁed a number of rhoptrylocalized proteins as substrates of PM X. Given that PM X was originally
found to be colocalized with SUB1 in the exoneme secretory organelles, these observations suggest that the interaction of PM X with its
substrates may be spatially regulated. We analyzed the processing of
PM X substrates under conditions where organellar discharge was
blocked by treatment with the C1. Control parasites were treated with
E64d to block parasite egress without impairing organellar discharge.
Processing of AMA1 (microneme), SUB1(exoneme) and Rh5 (rhoptry)
was assessed. As shown by western blot, both AMA1 and SUB1 were
processed in cells treated with C1 (Fig. 7a). On the other hand, treatment with C1 blocked the processing of Rh5, resulting in the accumulation of the 60 kDa precursor form (Fig. 7b). For Rh5 we could only
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Fig. 5 | The N-terminal half of the prodomain (PD) is critical for intracellular
trafﬁcking and functionality of PM X. a Scheme of PD truncation constructs that
are C-terminally GFP tagged and introduced into the PM Xapt line as second copies.
b Representative 2D confocal Airyscan images showing colocalization between the
second copy PM X and either SUB1-3xHA or PM V. Scale bar: 2 μm. The 3D version
of the images are shown in Supplementary Fig. 7. c Quantiﬁcation from Supplementary Fig. 7. Experiments were repeated two times, and for each line 10 schizonts were analyzed. Mean values are shown. Error bars represent standard
deviation. ***p < 0.001. For exact p values refer to the source ﬁle. d Zaprinastinduced discharge of second copy WT and delB but not delA mutant PM X from

41–44 h schizonts. Samples were treated with 75 μM zaprinast for 45 min. Supernatant was then separated from the cellular pellet followed by western blots with
indicated antibodies. Shown are the representative blots from two independent
experiments. e Growth curve of indicated parasite lines showing that the delA and
delPD mutants failed to rescue the growth defect due to knockdown of PM X. Mean
values from three independent experiments are shown and error bars represent
standard deviations. For c and e data were analyzed statistically by two-tailed
Student’s t test. P values in e represent comparison of delA mutant grown in
presence or absence of aTc at two time points. Source data are provided as a
Source Data ﬁle.

cellular compartments8. Similar partial colocalization was obtained
using EBA-175 as a microneme marker instead of AMA1 (Fig. 8a, b). Dual
labeling of PM X-3xHA-expressing terminal schizonts with either antiRON4 (rhoptry neck marker) or with anti-RAP1 (rhoptry bulb marker)
showed signiﬁcantly less overlap of signals (Fig. 8c). Consistent with
the Airyscan microscopy, imaging of parasites by the super-resolution
structured illumination microscopy (SR-SIM) revealed regions of
complete overlap between PM X and AMA1 or EBA-175 amid distinct
punctate patterns (Supplementary Fig. 11).
Given the small size of the merozoites and the proximity of the
organelles at the apical end of each merozoite, the regions of overlap

observed between AMA1 and PM X or AMA1 and SUB1 could be a result
of insufﬁcient resolution by ﬂuorescence microscopy. Therefore, to
better understand the localization of these proteins in schizonts, we
performed immunoelectron microscopy (immunoEM) on thin-section
schizont samples that were pretreated with C1. This revealed vesicles
that were single positive for either AMA1 or PM X-3xHA, as well as
vesicular structures showing signals for both proteins (Fig. 9a). Similar
observations were obtained when SUB1-3xHA schizonts were used
instead of PM X-3xHA schizonts (Fig. 9b). Although we could not
determine whether the single-positive vesicles bud from those that
contain both proteins, our data clearly indicate common partitioning
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of PM X and SUB1 with AMA1 inside the parasites, at least transiently.
Despite repeated attempts by immunoEM, we did not observe PM X or
SUB1 signal in the rhoptries (data not shown).

Discussion
Autoprocessing and activity of PM X
Aspartic proteases are canonically synthesized as proenzymes that
autoactivate by self-processing at the pro-mature junction, relieving
prodomain inhibition in the active site. The proenzyme form of PM X in
P. falciparum processes itself into multiple isoforms with different
N-termini and leaves some protein unprocessed. Using both recombinant enzyme and mutant parasites we mapped the PM X internal
cleavage sites. Mutations at the intra-prodomain region cleavage sites
could only abolish the formation of the intermediate forms, but not
the fully processed form, while mutations at the pro-mature junction
abolished the fully processed form but not the intermediate forms
(Fig. 1e). Thus, the different truncated forms of PM X originate from
independent processing events at alternative cleavage sites.

Fig. 6 | PM X is processed in terminal secretory compartments in the parasites.
Synchronized 40–43 h schizonts expressing PM X-3xHA were treated separately
with the vehicle (DMSO), E64d (10 μM) and C1 (1.5 μM) for 8 h. Samples were
fractionated to separate the secreted (supernatant) components from those that
remained intracellular (merozoites). PM X-3xHA was pulled down using anti-HA
antibody. Western blot was done with both fractions to assess distribution of PM X.
Aliquots were blotted for PM V as an intracellular control. Shown are representative
blots from two independent experiments. Source data are provided as a Source
Data ﬁle.

Fig. 7 | PM X cleaves microneme substrates intracellularly, while rhoptry
substrate cleavage is mediated in a post-secretion manner. a, b PM Xapt parasites were grown in presence or absence of aTc to the schizont stage. At 44 h post
invasion, either C1 (1.5 μM) or E64d (10 μM) was added to the +aTc cultures for 6 h
before harvesting. Samples were blotted assess the cleavage of either AMA1

Nature Communications | (2022)13:4537

https://doi.org/10.1038/s41467-022-32271-7

To our surprise, a quadruple mutant PM X that fails to undergo
any cleavage, showed robust in vitro substrate cleavage activity, and
could fully complement parasite growth in absence of endogenous PM
X (Figs. 2 and 3). An ER resident protein, PfERC (Plasmodium falciparum endoplasmic reticulum-resident calcium-binding protein) has
been implicated in the activation of PM X24. Knockdown of PfERC gave
rise to a defect in the PM X-mediated processing step of SUB1, leading
to a block in parasite egress. In those parasites, PM X accumulated in
the full-length form. Our current data suggest that the observed loss of
PM X functionality was likely not due to the lack of proteolytic
processing.
How then is the activation of the PM X proenzyme regulated?
Earlier, rPM X was shown to be active at pH 5.53–5. However, it was not
clear why acidic conditions are required for activity. Recently, two
independent studies based on the crystal structures of the recombinant PfPM X reported unique folds within its PD segment12,25. Importantly, a twisted loop within the N terminal part of the PD (R95 to G104)
has been shown to occupy the substrate binding pockets in the
proenzyme. Additional salt bridges between the PD and the mature
domain (R95 and E433) and within the mature domain (R244 with the
catalytic D266 and D457) have been implicated in maintaining the inactive
state. Like the other autocatalytic pepsin-like proteases, therefore, a
drop in pH has been proposed to break the salt bridges, destabilizing
the inhibitory PD, and thereby leading to PM X activation14. The pH
dependency of rPM X for substrate cleavage supports this theory
(Supplementary Fig. 6). Importantly, an N-terminal fragment of the PD
remained noncovalently attached to the rest of the protease even
under activation conditions (Fig. 4a, c). This indicates that the acidityinduced activation of PM X does not require physical separation
of the PD.
Activity of parasite-derived PM X was also regulated by pH (Fig. 3).
Nevertheless, the quadruple mutant was signiﬁcantly less active than
the WT PM X at pH 6.5. This suggests that while PD cleavage is not
necessary, it can increase the substrate cleavage efﬁciency of PM X
under some conditions. In parasites, however, the different cleavage
mutant forms did not show a discernable defect in processing of SUB1
and AMA1 (Fig. 2b). PM X has a broad range of substrates and many of
them are parasite surface adhesins5. The cleavage efﬁciency of the
different mutant forms of PM X towards these adhesins was not tested
here. It is possible defects in PM X-mediated processing might alter the
antigenicity of different surface adhesins, and therefore might change
how the surface epitopes are presented to the host immune cells.
Being an intracellular pathogen that normally stays outside of its host

(a microneme substrate) or Rh5 (b rhoptry substrate). Processing of SUB1 and
SERA5 were analyzed from the same lysates as indicators of PM X activity and
exoneme discharge respectively. Each blot was repeated at least twice. Source data
are provided as a Source Data ﬁle.
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Fig. 8 | PM X and SUB1 signals overlap signiﬁcantly more with microneme
markers (AMA1 and EBA175) than with rhoptry neck (RON4) or bulb (RAP1)
markers in terminal schizonts. Synchronized, C1-treated 48–50 h schizonts
expressing either PM X-3xHA or SUB1-3xHA were ﬁxed in paraformaldehyde and
processed for immunoﬂuorescence assays. After labeling with the indicated antibodies, samples were visualized by confocal Airyscan microscopy. Images in a are
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2D snapshots. 3D reconstructions are shown in b. Each grid line in b is 1.61 μm.
Shown are representative images from two independent experiments.
c Quantiﬁcation of the 3D images from b. For each line, 10 schizonts were analyzed
from three biological replicates. Mean values are shown and error bars represent
standard deviations. Data were analyzed statistically by two-tailed Student’s t test,
p values are shown on the graphs. Source data are provided as a Source Data ﬁle.
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Fig. 9 | A subset of the apically located vesicles in schizonts show colocalization
between AMA1 and PM X or SUB1 by immunoEM. Synchronized, C1-treated,
48–50 h schizonts expressing either PM X-3xHA (a) or SUB1-3xHA (b) were processed as described in the methods. Thin section samples were labeled for the
indicated markers and visualized by immunoelectron microscopy. Black arrows:

18 nm beads that detect the anti HA antibody, yellow arrows: 12 nm beads that
detect the anti AMA1 antibody. Sections showing apical vesicles are magniﬁed from
each image. R rhoptry, N nucleus. Shown are representative images from two
independent experiments.

RBC only for short period of time between egress and re-invasion,
variation in antigenicity might, therefore, cost parasite replication
in vivo.

By using two different high-resolution immunoﬂuorescence
techniques, along with immunoelectron microscopy, we observed
an intimate association between the microneme and exoneme
markers (Fig. 8 and Supplementary Fig. 10). Some signal was
overlapping and by EM could be seen together in vesicular structures, suggesting that the two organelles might have a common
base. Based on these data, therefore, we propose that the microneme and exoneme proteins co-trafﬁc to a precursor compartment where PM X encounters an acidic environment and
subsequently cleaves its substrates. Further sorting of the proteins
from such precursor compartments might result in the heterogeneity of the micronemes and exonemes.
It is still not clear why some rhoptry substrates are cleaved by PM
X. In T. gondii, a PM IX/ X ortholog ASP3 has been shown to process
both microneme and rhoptry substrates27. In contrast, the Plasmodium

Interaction of PM X with different substrates is spatially
regulated
We showed that the PM X-mediated processing of the exonemelocalized substrate SUB1 and the microneme-localized substrate AMA1
take place exclusively inside the parasites (Fig. 7a). In contrast, the
rhoptry substrate Rh5 was processed following apical organellar discharge, likely inside the PV (Fig. 7b). Given that PM X needs acidic pH
for activity, this may indicate that the PV becomes acidic prior to
egress. In the related apicomplexan parasite Toxoplasma gondii, a pH
decrease in the PV towards the end of the replication cycle has been
reported26.
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genome encodes a separate rhoptry-speciﬁc aspartic protease, plasmepsin IX (PM IX)3,4. Importantly, PM IX and PM X have similar substrate speciﬁcity in vitro5. This suggests that the exposure of different
substrates to these proteases in Plasmodium is rather complex and
might be both spatially and temporally regulated. While the molecular
determinants remain to be identiﬁed, sub-compartmentalization of
different proteins inside the rhoptries have been documented28,29. It is
believed that this organization regulates interaction between different
proteins within the rhoptries and as well as the timing of protein
secretion. Rh5 along with other Rhs are located at the very tip of the
rhoptries where PM IX is excluded, and therefore, it is possible that Rh5
is not accessible to PM IX3,4,11. Moreover, while it remains unknown how
PM X-mediated cleavage regulates Rh5 function, we have shown that
PM X is secreted inside the PV (Fig. 6), where we propose that the
cleavage happens. Whether PM IX is a secreted protease remains
unknown.

Methods
Reagents
All primers were obtained from Integrated DNA Technologies. List of
primers used in this study can be found in the Supplementary Table 2.
Restriction enzymes were purchased from New England Biolabs.
Compound 1 was purchased from MedChem Express. E64d and
zaprinast were purchased from Sigma. Ni-NTA beads, anti-HA and the
anti-GFP antibodies coated magnetic beads were from ThermoFisher
and Chromotek respectively. The rat anti-FLAG antibody was from
Novus Biologicals, the mouse-anti HA antibody was from Biolegend,
the rabbit anti-HA antibody and the rabbit anti-His antibody were from
Sigma, the rabbit anti-AMA1 antibody was from LSBio, the mouse antiGFP antibody (JL-8) was from Takara. Monoclonal antibodies 2.29 (antiRAP1) and 12.4 (anti-MSP1) were obtained from The European Malaria
Reagent Repository (http://www.malariaresearch.eu). The anti-EBA175
antibody (MRA-2) was from MR-4. The mouse anti-PM V antibody was
previously described30. Anhydrotetracycline (aTc) was purchased from
Cayman Chemical. Synthetic PM X substrate peptides were from
Eurogentec. List of the primary antibodies and dilutions used can be
found in the Supplementary Table 3.

Generation of plasmids
To complement the PM X knockdown, we modiﬁed the previously
described pyEOE-2X attP-3X MYC vector3. At ﬁrst, the yDHOD cassette
was replaced with the human dihydrofolate reductase (hDHFR),
resulting into the vector pEOE-2X attP. To make PM X expression stagespeciﬁc, we used a 1700 bp sequence located upstream of the AMA1
coding region. This promoter (pAMA1) has been successfully used for
transgenic expression of other late-stage-speciﬁc genes in P.
falciparum10,31. The pAMA1 was ampliﬁed from genomic DNA of the
NF54 strain of P. falciparum using the primer pair 151 and 152 and
subsequently gel extracted. The puriﬁed fragment was ligated between
the AﬂII and XhoI restriction enzymes cut sites within pEOE-2X attP
generating pEOE-pAMA1-2X attP. The ORF of PM X was ampliﬁed using
the primers 153 and 154. The ORF of green ﬂuorescence protein (GFP)
was PCR-ampliﬁed from the plasmid PM2GT32 using the primers 155
and 156. Ampliﬁed PM X and GFP ORFs were subsequently fused by
Gibson assembly with the pEOE-pAMA1-2X attP that was previously
digested with XhoI and EagI. This resulted in the production of the ﬁnal
WT complementation construct pEOE-PM X-GFP-2XattP. Subsequent
site-directed mutagenesis (QuickChange lightning, Agilent) on this
plasmid used primers 157, 158, 159 and 160 to generate the different
PM X cleavage mutant constructs. For generating the different PD
truncation mutant constructs, pEOE-PM X-GFP plasmid was subjected
to site-directed mutagenesis. Mutagenesis primers 161 and 162 were
used to generate the delA and delB constructs respectively. DelPD
construct was made in a similar way using primer 163. Tagging the
endogenous ORF of SUB1 with 3xHA was carried out using previously

Nature Communications | (2022)13:4537

https://doi.org/10.1038/s41467-022-32271-7

published plasmids3. The different cleavage mutant constructs for
recombinant PM X were made from the parental construct using the
primers shown in Supplementary Table 2.

Parasite culture and transfection and synchronization
NF54attB parasites33 and resultant transgenic strains were cultured in
human red blood cells as previously described34. PM Xapt parasites3
were maintained in presence of 100 nM aTc and 2.5 μg/ml BSD. For
complementation of PM X, plasmids carrying WT or mutant PMX
coding sequences were independently co-transfected with a Bxb1
integrase plasmid35 into the PMXapt parasites. Parasites were selected
with 5 nM WR, together with 2.5 μg/ml BSD and 1 μM aTc. The integration of these plasmids into the PMXapt strain was conﬁrmed by PCR
using the primer pair 164 and 165. For tagging the 3’ end of SUB1, the
NF54attB parasites were cotransfected with the yPM2GT-SUB1-3xHA
and the pAIO3 guide plasmids. The transfectants were selected in the
presence of 12.5 μg/ ml DSM1. Integration of the plasmid was veriﬁed by PCR.
Highly synchronous ring-stage parasites were obtained as follows.
High-parasitemia schizont cultures were passed through MACS LD
magnet columns (Miltenyi Biotec) and schizonts were collected. These
were then added to fresh uninfected RBCs resuspended in warm culture media. The cultures were shaken at 80 RPM for 3 h and the
resulting parasites were synchronized using 5% sorbitol as described
before36.

Parasite growth assay
For growth curves, synchronized ring-stage parasites were washed
extensively to remove residual aTc and were diluted to an initial 1%
parasitemia at 2% hematocrit. Cultures were split and aTc was added to
appropriate wells. Parasitemia was determined every 24 h using ﬂow
cytometry as described previously3.

Natural and zaprinast-induced parasite egress assays
To follow natural parasite egress, 41–44 h schizonts expressing PM
X-3xHA were MACS- puriﬁed and treated with either vehicle (DMSO) or
with E64d (10 µM) for 8 h. A third sample was treated similarly with the
PKG inhibitor C1 (1.5 µM) to block discharge from the apical
organelles19. Following incubation, the discharged proteins (in the
culture supernatant) were separated from those that remained intracellular by centrifuging the cultures at 10,000 × g for 10 min. PM X was
subsequently pulled down using anti-HA beads and subjected to
western blot.
Zaprinast-induced organellar discharge was performed as
described previously19. Brieﬂy, 41–44 h synchronized parasites were
MACS puriﬁed and transferred to albumax-free medium. Zaprinast
(75 µM) was added to the cultures and samples were either harvested
immediately (0 min) or after 45 min of incubation. Culture supernatants were separated from the intracellular fractions as mentioned.
Endogenous or second copy PM X was pulled down from both fractions using anti-FLAG and anti-GFP antibodies respectively, followed
by western blot.

Brefeldin A sensitivity assay
To determine the effect of brefeldin A (BFA) on the processing of PM X,
a pulse-chase assay was performed as before37. Brieﬂy, synchronized
cultures of schizont-infected RBCs were washed once in RPMI without
methionine and cysteine, resuspended in labeling medium (RPMI
without methionine and cysteine) containing 250 µCi/ml [35S]
methionine-cysteine (PerkinElmer) and incubated at 37 °C for 5 min.
Cultures were either harvested immediately or maintained in label-free
complete medium containing 10 µg/ml cycloheximide for 60 min at
37 °C before harvest. During incubation, BFA (5 µg/ml) was added to
one culture. Subsequently, PM X-3xHA was pulled down, resolved by
SDS-PAGE and subjected to autoradiography.
10
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Expression and puriﬁcation of recombinant PM X (rPM X) from
mammalian cells
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The rPM X expression vector for mammalian cells was a gift from UCB
Pharma, USA. In this construct, a mammalian recodonized version of
PM X was C-terminally tagged with 8x-histidine (8x-His) and the
endogenous signal peptide at the N-terminal end was replaced with a
mammalian signal peptide. For protein expression, the Freestyle 293-F
cells (Thermo Fisher) were transfected with a mixture of DNA and
polyethylenimine (1:3). The rPM X was expressed as a secreted protein.
72 h post transfection the supernatant was harvested. The diluted
supernatant (1: 3 in 50 mM Tris-Cl pH 8.0, 100 mM NaCl, 10 mM imidazole) was puriﬁed using Ni-NTA resin (ThermoFisher). After extensive wash in the same buffer, the protein was eluted with 50 mM Tris-Cl
pH 8.0, 100 mM NaCl, 400 mM imidazole. The eluted sample was then
buffer exchanged using an Amicon ultra 3 kDa molecular wt. cutoff
ﬁlter (Millipore, USA) and ﬁnally resuspended in 50 mM Tris pH 7.5,
100 mM NaCl. If not used immediately, 1% glycerol was added and the
preparation was stored in −80 °C.

Scientiﬁc) mass spectrometer using a 2 h gradient. Peptides were
resolved in a 75 µm × 50 cm PepMap C18 column (Thermo Scientiﬁc)
with following gradient: Time = 0–4 min, 2% B isocratic; 4–8 min,
2–10% B; 8–83 min, 10–25% B; 83–97 min, 25–50% B; 97–105 min,
50–98%. Mobile phase consisted of A, 0.1% FA; mobile phase B, 0.1% FA
in ACN. The instrument was operated in the data-dependent acquisition mode in which each MS1 scan was followed by Higher-energy
collisional dissociation (HCD) of as many precursor ions in 2 s cycle
(Top Speed method). The mass range for the MS1 done using the FTMS
was 365–1800 m/z with resolving power set to 60,000 at 400 m/z and
the automatic gain control (AGC) target set to 1,000,000 ions with a
maximum ﬁll time of 100 ms. The selected precursors were fragmented in the ion trap using an isolation window of 1.5 m/z, an AGC
target value of 10,000 ions, a maximum ﬁll time of 100 ms, a normalized collision energy of 35 and activation time of 30 ms. Dynamic
exclusion was performed with a repeat count of 1, exclusion duration
of 30 s, and a minimum MS ion count for triggering MS/MS set to 5000
counts.

Circular dichroism (CD) spectroscopy assay

Data analysis

To examine the secondary structure of rPM X, samples were diluted to
35 ug/ ml in 10 mM potassium phosphate buffer with indicated pHs.
CD spectra were recorded on a JASCO-J715 polarimeter (JASCO, Tokyo,
Japan) over the wavelength range 185–325 nm in a 1-mm path length
quartz cuvette using a step size of 0.5 nm, a slit bandwidth of 1.0 nm,
and a signal averaging time of 1.0 s. For each wavelength three scans
were performed. AVIV software was used for background subtraction.
Molar ellipticity [θ] was calculated using the formula: [θ] = θ(mdeg)/
10∙C (mol/lit) ∙l(cm), where C is the concentration of the sample, l is the
path length. For estimation of secondary structure composition, the
online server K2D3 was used.

All MS/MS samples were analyzed using Mascot (Matrix Science,
London, UK; version 2.5.1.0). Mascot was set up to search against
provided sequence along with common contaminants. The digestion
enzyme was set as semiTrypsin (to account for nontryptic termini).
Mascot was searched with a fragment ion mass tolerance of 0.60 Da
and a parent ion tolerance of 10 ppm. Oxidation of methionine, carbamidomethylation of cysteine, and acetylation of N-terminal of protein were speciﬁed in Mascot as variable modiﬁcations. Scaffold
(version Scaffold_4.8.2 Proteome Software Inc., Portland, OR) was used
to validate MS/MS based peptide and protein identiﬁcations. Peptide
identiﬁcations were accepted if they could be established under 1%
FDR by the Peptide Prophet algorithm39 with Scaffold delta-mass correction. Protein identiﬁcations were accepted if they could be established at greater than 99.0% probability and contained at least 2
identiﬁed peptides. Protein probabilities were assigned by the Protein
Prophet algorithm40. The mass spectrometry proteomics data have
been deposited to the ProteomeXchange Consortium via the PRIDE41
partner repository with the dataset identiﬁer PXD035172 and 10.6019/
PXD035172.

In vitro substrate cleavage assay
The ability of rPM X to cleave ﬂuorogenic substrate peptides was
performed as described4,5. Brieﬂy, 25 ng of rPM X was incubated with
1 µM DABCYL-HSFIQEGKE-E-EDANS (Rh2N peptide) in 200 µl of PM X
activity buffer (25 mM MES, 25 mM Tris, pH 5.5) for 40 min at 37 °C. As
a negative control, a point mutant form of the peptide (DABCYLHSFAAEGKE-E-EDANS) that is not cleaved by PM X was used as a substrate. To inhibit PM X activity, 1 µM CWHM-1173,38 was added to samples at pH 5.5. Each sample was analyzed in triplicate using a Synergy
HTX microplate reader at 340 nm wavelength. Readings were taken at
1 min intervals. PM X activity was measured as an increase in the relative ﬂuorescence units (RFUs) over time. Shown are the ﬁnal RFU
values after 40 min of reaction.
To determine the activity of parasite-derived PM X, synchronized
42–45 h schizonts (2 × 107 cells per sample) expressing PM X-GFP were
lysed in ice-cold native lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl,
1% NP-40). PM X-GFP was pulled down from whole cell lysates using
anti-GFP antibody-coated magnetic beads (Chromotek) according to
the manufacturer’s recommendations. Following washes (4×) in the
lysis buffer, beads were incubated with the Rh2N substrate peptide
(1 µM) in 200 µL of PM X activity buffer. Fluorescence readings were
taken either immediately or following 1 h incubation in 37 °C.

Liquid chromatography/Mass spectrometry (LC/MS)
To determine the cleavage sites of the processed products in rPM X,
the indicated bands in Fig. 1A were excised from the gel and were
subjected to LC/MS analysis. Brieﬂy, the gel samples were destained,
reduced and alkylated prior to trypsin digestion. Digest was aspirated
and combined with further extraction of the gel piece with 60% acetonitrile (ACN) in 1% triﬂuoroacetic acid (TFA). The extracted peptides
were dried down and each sample was resuspended in 10 µL 5% ACN/
0.1% formic acid (FA). 5 µL was analyzed by LC-MS with a Dionex
RSLCnano HPLC coupled to an Orbitrap Fusion Lumos (Thermo
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Size exclusion chromatography
For gel ﬁltration, rPM X samples were pretreated in acidic PM X activation buffer (25 mM MES, 25 mM Tris, pH 5.5) or in the same buffer
with a pH 7.5 for 30 min at room temperature. Before sample runs, the
Superdex 200 10/300 column (GE Healthcare) was equilibrated in the
same buffer. Following runs, the samples were collected as 0.5 ml
fractions. Fractions of interest (as indicated in Fig. 4b and Supplementary Fig. 4a) were further concentrated using an Amicon ultra
3 kDa mol. wt. cutoff ﬁlter. Finally, samples were resolved by SDS-PAGE
and the gel was stained with Coomassie dye. For gel ﬁltration under
denaturation, every step was done as mentioned except that the buffers were supplemented with 6 M guanidine hydrochloride. For
denaturation, sample was treated with 6 M guanidine hydrochloride
and heated at 60 °C for 45 min before loading onto the size exclusion
column. As a control for acidity-induced dissociation of subunits,
human hemoglobin A tetramers were treated in the same buffers as
rPM X followed by gel ﬁltration.

Dynamic Light Scattering (DLS)
To determine the size distribution proﬁle of rPM X in pH 5.5 buffer, a
DLS experiment was performed with the indicated fractions obtained
from size exclusion chromatography. Sample concentration was
adjusted to 0.5 mg/ ml. Brieﬂy, 40 ul of sample was taken in disposable
polystyrene cuvettes and subsequently the light scattering was measured in a Malvern ZEN3600 instrument ﬁtted with a 632 nm laser
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illuminating source. Each sample was measured in duplicates. Following sample run, all analysis was performed using the Zetasizer
7.13 software. PyMOL 2.4.1 was used to determine the diameter of the
recombinant PM X (PDB: 7RY7).

Western blots
For PM X knockdown western blots (Fig. 2b), following synchronization, each culture was split into two plates. To one plate, aTc was
added, and to the other equal volume of vehicle (DMSO) was added.
46 h post invasion, schizonts were collected by saponin lysis and
stored at −80 °C until further processing. Samples were subsequently
lysed in RIPA buffer supplemented with protease inhibitor cocktail and
hemozoin was removed by centrifugation. Cell lysates were mixed
with 4x sample loading buffer and heated at 99 °C for 5 min. Fractions
of equal cell equivalents were subjected to SDS-PAGE and
immunoblotting.
For processing inhibition assays (Fig. 7), PM Xapt parasites were
synchronized and grown up to 44 h of age, as above. The infected RBCs
from +aTc were then separated by MACS and resuspended in a small
volume supplemented with either E64d (10 µM) or with compound 1
(1.5 µM) for the next 6 h. Cultures were then separated from the culture
supernatant and the pellet fractions were boiled with 2× sample
loading buffer.
Primary antibodies included rabbit anti-AMA1 (1:500), rabbit antiSUB1 (1:1000), rabbit anti-HA (1:1000), rabbit anti-Sera5 (1:1000),
mouse anti PM V (1:500), rabbit anti-Rh5 (1:500), mouse anti-GFP
(1:1000), mouse anti-his (1:1000), and rat anti-FLAG (1:1000). For all,
appropriate IRDye conjugated secondary antibodies were used at
1:10000 dilution. Blots were visualized on an Odyssey imaging system (Licor).

Immunoﬂuorescence assays
For IFAs, cells were ﬁxed as described previously42. Brieﬂy, synchronized and C1-treated mature schizonts were ﬁxed in 3.7% paraformaldehyde for 15 min and blocked in 3% BSA in PBS overnight at 4 °C
before antibody staining. The antibodies used for IFA were: rabbit antiHA (1:500), mouse anti-HA (1:500), mouse anti-GFP (1:500), mouse
anti-MSP1 (1:500), rabbit anti-AMA1 (1:500), mouse anti-RAP1 (1:500),
rabbit anti-EBA175 (1:500), rabbit anti-RON4 (1:500) and mouse antiPM V (1:50). The secondary antibodies were used as 1:2000 dilutions
and were conjugated to Alexa Fluor 488 or 546 (Life Technologies).
Cells were mounted with ProLong and 4’,6’-diamidino-2-phenylindole
(DAPI) (Invitrogen) and imaged using a Zeiss Imager M2 Plus wide ﬁeld
ﬂuorescence microscope, using a 63x objective and the Axiovision
4.8 software for epiﬂuorescence imaging.
For confocal imaging, samples were analyzed with a Zeiss LSM880
laser scanning confocal microscope with Airyscan (Carl Zeiss Inc.
Thornwood, NY). A Plan-Apochromat 63X (NA 1.4) DIC objective and
ZEN black software (version 2.1 SP3) were used for image acquisition.
The image analysis software Volocity (version 6.3) (PerkinElmer, Waltham, MA) was used for 3-dimensional rendering of Z slices acquired
through the depth of the parasites. For SR-SIM microscopy, images
were captured with a Nikon SIM super resolution microscope under a
100x objective using the Nikon NIS software. Image processing and
display were performed using Zen Blue. Adjustments to brightness and
contrast were made for display purposes.
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Leica Ultracut UCT cryo ultramicrotome (Leica Microsystems Inc.,
Bannockburn, IL). 50 nm sections were blocked with 5% FBS/5% NGS
for 30 min and subsequently incubated with primary antibodies for 1 h,
followed by secondary antibodies conjugated to 12 nm or 18 nm colloidal gold (1:30) for 1 h. Sections were washed in PIPES buffer followed
by a water rinse, and stained with 0.3% uranyl acetate/2% methyl cellulose and viewed on a JEOL 1200EX transmission electron microscope
(JEOL USA, Peabody, MA) equipped with an AMT 8 megapixel digital
camera (Advanced Microscopy Techniques, Woburn, MA). All labeling
experiments were conducted in parallel with controls omitting the
primary antibody, which were consistently negative at the concentration of colloidal gold-conjugated secondary antibodies used in these
studies.

Statistical analysis
Unless speciﬁed otherwise, assay values in all ﬁgures are averaged from
three independent repeats and error bars represent standard deviations. Differences were assessed by the two-tailed Student’s t test using
the Microsoft Excel software. For quantiﬁcation of colocalization in
Figs. 5c and 8c confocal Airyscan images were analyzed by ImageJ and a
Pearson’s colocalization coefﬁcient was determined for the indicated
antigen pairs. P values indicating statistical signiﬁcance were grouped
in all ﬁgures. All graphs were prepared using GraphPad Prism 8.

Reporting summary
Further information on research design is available in the Nature
Research Reporting Summary linked to this article.

Data availability
Authors can conﬁrm that all relevant data are included in the paper
and/ or its supplementary information ﬁles. Source data are provided
as a Source Data ﬁle. Additional supplementary information for LC/ MS
are included as Supplementary Data 1, Supplementary Data 2 and
Supplementary Data 3. The lists of primers and the details of the primary antibodies used are included as Supplementary Table 2 and
Supplementary Table 3 respectively. The crystal structure of PM X that
was used in this study is deposited in the protein data base (PDB) under
PDB ID: 7RY7. The mass spectrometry proteomics data have been
deposited to the ProteomeXchange Consortium via the PRIDE partner
repository with the dataset identiﬁer PXD035172 and 10.6019/
PXD035172. Source data are provided with this paper.

References
1.
2.

3.

4.

5.

6.

Immunoelectron microscopy
Samples for immunoEM were prepared as before3. Brieﬂy, the infected
RBCs were ﬁxed in 4% paraformaldehyde (Polysciences Inc., Warrington, PA) with 100 mM PIPES/0.5 mM MgCl2, pH 7.2 for 1 h at 4 °C.
Samples were then embedded in 10% gelatin and inﬁltrated overnight
with 2.3 M sucrose/20% polyvinyl pyrrolidone in PIPES/MgCl2 at 4 °C.
Samples were trimmed, frozen in liquid nitrogen, and sectioned with a

Nature Communications | (2022)13:4537

7.

WHO. WHO World Malaria Report 2020 (WHO, 2020).
Autino, B., Corbett, Y., Castelli, F. & Taramelli, D. Pathogenesis of
malaria tissues and blood. Mediterr. J. Hematol. Infect. Dis. 4,
e2012061 (2012).
Nasamu, A. S. et al. Plasmepsins IX and X are essential and druggable mediators of malaria parasite egress and invasion. Science
358, 518–522 (2017).
Pino, P. et al. A multistage antimalarial targets the plasmepsins IX
and X essential for invasion and egress. Science. https://doi.org/10.
1126/science.aaf8675 (2017).
Favuzza, P. et al. Dual plasmepsin-targeting antimalarial agents
disrupt multiple stages of the malaria parasite life cycle. Cell Host
Microbe https://doi.org/10.1016/j.chom.2020.02.005 (2020).
Thomas, J. A. et al. A protease cascade regulates release of the
human malaria parasite Plasmodium falciparum from host red
blood cells. Nat. Microbiol. https://doi.org/10.1038/s41564-0180111-0 (2018).
Das, S. et al. Processing of plasmodium falciparum merozoite surface protein MSP1 activates a spectrin-binding function enabling
parasite egress from RBCs. Cell Host Microbe https://doi.org/10.
1016/j.chom.2015.09.007 (2015).

12

Article
8.

9.

10.
11.

12.

13.

14.

15.

16.
17.
18.

19.

20.
21.

22.

23.

24.

25.

26.

27.
28.

Yeoh, S. et al. Subcellular discharge of a serine protease mediates
release of invasive malaria parasites from host erythrocytes. Cell
https://doi.org/10.1016/j.cell.2007.10.049 (2007).
Healer, J., Crawford, S., Ralph, S., McFadden, G. & Cowman, A. F.
Independent translocation of two micronemal proteins in developing Plasmodium falciparum merozoites. Infect. Immun. 70,
5751–5758 (2002).
Child, M. A. et al. Molecular determinants for subcellular trafﬁcking
of the malarial sheddase PfSUB2. Trafﬁc 14, 1053–1064 (2013).
Counihan, N. A., Kalanon, M., Coppel, R. L. & De Koning-Ward, T. F.
Plasmodium rhoptry proteins: Why order is important. Trends
Parasitol. 29, 228–236 (2013).
Kesari, P. et al. Structures of plasmepsin X from Plasmodium falciparum reveal a novel inactivation mechanism of the zymogen and
molecular basis for binding of inhibitors in mature enzyme. Protein
Sci. 31, 882–899 (2022).
Pandey, K. C., Sijwali, P. S., Singh, A., Na, B.-K. & Rosenthal, P. J.
Independent intramolecular mediators of folding, activity, and
inhibition for the Plasmodium falciparum cysteine protease
falcipain-2. J. Biol. Chem. 279, 3484–3491 (2004).
Khan, A. R., Khazanovich-Bernstein, N., Bergmann, E. M. & James, M.
N. G. Structural aspects of activation pathways of aspartic protease
zymogens and viral 3C protease precursors. Proc. Natl Acad. Sci.
USA 96, 10968–10975 (1999).
Huang, Y.-X., Wu, Z.-J., Huang, B.-T. & Luo, M. Pathway and
mechanism of pH dependent human hemoglobin tetramer-dimermonomer dissociations. PLoS One 8, e81708 (2013).
Boddey, J. A. et al. An aspartyl protease directs malaria effector
proteins to the host cell. Nature 463, 627–631 (2010).
Russo, I. et al. Plasmepsin V licenses Plasmodium proteins for
export into the host erythrocyte. Nature 463, 632–636 (2010).
Klemba, M. & Goldberg, D. E. Characterization of plasmepsin V, a
membrane-bound aspartic protease homolog in the endoplasmic
reticulum of Plasmodium falciparum. Mol. Biochem. Parasitol. 143,
183–191 (2005).
Collins, C. R. et al. Malaria parasite cGMP-dependent protein kinase
regulates blood stage merozoite secretory organelle discharge and
egress. PLoS Pathog. 9, e1003344 (2013).
Glushakova, S., Mazar, J., Hohmann-marriott, M. F. & Hama, E.
Malaria parasites from infected erythrocytes. Cell 11, 95–105 (2010).
Wickham, M. E., Culvenor, J. G. & Cowman, A. F. Selective inhibition
of a two-step egress of malaria parasites from the host erythrocyte.
J. Biol. Chem. 278, 37658–37663 (2003).
Elmendorf, H. G. & Haldar, K. Identiﬁcation and localization of ERD2
in the malaria parasite Plasmodium falciparum: separation from
sites of sphingomyelin synthesis and implications for organization
of the Golgi. EMBO J. 12, 4763–4773 (1993).
Klausner, R. D., Donaldson, J. G. & Lippincott-Schwartz, J. Brefeldin
A: insights into the control of membrane trafﬁc and organelle
structure. J. Cell Biol. 116, 1071–1080 (1992).
Fierro, M. A. et al. An endoplasmic reticulum CREC family protein
regulates the egress proteolytic cascade in malaria parasites. MBio
11, e03078-19 (2020).
Hodder, A. N., Scally, S., Triglia, T., Dietrich, M. H. & Olsen, D. Basis
for drug selectivity of plasmepsin IX and X inhibition for Plasmodium falciparum and vivax. Structure. 30, 947–961.e6 (2022).
Roiko, M. S., Svezhova, N. & Carruthers, V. B. Acidiﬁcation
activates toxoplasma gondii motility and egress by enhancing
protein secretion and cytolytic activity. PLoS Pathog. 10,
e1004488 (2014).
Dogga, S. K. et al. A druggable secretory protein maturase of Toxoplasma essential for invasion and egress. Elife 6, e27480 (2017).
Richard, D. et al. Identiﬁcation of rhoptry trafﬁcking determinants
and evidence for a novel sorting mechanism in the malaria parasite
Plasmodium falciparum. PLoS Pathog. 5, e1000328 (2009).

Nature Communications | (2022)13:4537

https://doi.org/10.1038/s41467-022-32271-7
29. Baum, J. et al. Reticulocyte-binding protein homologue 5 - An
essential adhesin involved in invasion of human erythrocytes by
Plasmodium falciparum. Int. J. Parasitol. https://doi.org/10.1016/j.
ijpara.2008.10.006 (2009).
30. Banerjee, R. et al. Four plasmepsins are active in the Plasmodium
falciparum food vacuole, including a protease with an active-site
histidine. Proc. Natl Acad. Sci. USA 99, 990–995 (2002).
31. Olivieri, A. et al. Juxtamembrane shedding of Plasmodium falciparum AMA1 is sequence independent and essential, and helps
evade invasion-inhibitory antibodies. PLoS Pathog. 7,
e1002448 (2011).
32. Klemba, M., Beatty, W., Gluzman, I. & Goldberg, D. E. Trafﬁcking of
plasmepsin II to the food vacuole of the malaria parasite Plasmodium falciparum. J. Cell Biol. 164, 47–56 (2004).
33. Adjalley, S. H. et al. Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking
activity by methylene blue. Proc. Natl Acad. Sci. USA 108,
E1214–E1223 (2011).
34. Istvan, E. S. et al. Esterase mutation is a mechanism of resistance to
antimalarial compounds. Nat. Commun. 8, 14240 (2017).
35. Nkrumah, L. J. et al. Efﬁcient site-speciﬁc integration in Plasmodium
falciparum chromosomes mediated by mycobacteriophage Bxb1
integrase. Nat. Methods 3, 615–621 (2006).
36. Lambros, C. & Vanderberg, J. P. Synchronization of Plasmodium
falciparum erythrocytic stages in culture. J. Parasitol. 65,
418–420 (1979).
37. Banerjee, R., Francis, S. E. & Goldberg, D. E. Food vacuole plasmepsins are processed at a conserved site by an acidic convertase
activity in Plasmodium falciparum. Mol. Biochem. Parasitol. https://
doi.org/10.1016/S0166-6851(03)00119-1 (2003).
38. Meyers, M. J. et al. Evaluation of aminohydantoins as a novel class of
antimalarial agents. ACS Med. Chem. Lett. 5, 89–93 (2014).
39. Keller, A., Nesvizhskii, A. I., Kolker, E. & Aebersold, R. Empirical
statistical model to estimate the accuracy of peptide identiﬁcations
made by MS/MS and database search. Anal. Chem. 74,
5383–5392 (2002).
40. Nesvizhskii, A. I., Keller, A., Kolker, E. & Aebersold, R. A statistical
model for identifying proteins by tandem mass spectrometry. Anal.
Chem. 75, 4646–4658 (2003).
41. Perez-Riverol, Y. et al. The PRIDE database resources in 2022: a hub
for mass spectrometry-based proteomics evidences. Nucleic Acids
Res. 50, D543–D552 (2022).
42. Absalon, S. et al. Calcium-dependent protein kinase 5 is required
for release of egress-speciﬁc organelles in plasmodium falciparum.
MBio 9, e00130-18 (2018).

Acknowledgements
This work was supported by grant AI138447 from the National
Institute of Allergy and Infectious Diseases (NIAID) to D.E.G. We
thank Dr. Wandy Beatty (WUSTL) for immune-electron microscopy,
the Molecular Microbiology Imaging Facility at WUSTL for confocal
Airyscan microscopy and the Washington University Center for
Cellular Imaging (WUCCI) for SR-SIM microscopy, the Washington
University nano research facility for Dynamic Light Scattering
experiment, the Proteomics & Mass Spectrometry Facility at the
Danforth Plant Science Center for LC/MS data acquisition and analysis, Dr. Bob Krantz (WUSTL) and Dr. David Sibley (WUSTL) for usage
of the JASCO-J715 polarimeter and the Synergy HTX microplate
reader respectively, Dr. Michael J. Blackman (The Francis Crick
Institute, London) for anti-SUB1 and SERA5 antibodies, Dr. JeanFrançois Dubremetz (University of Montpellier, France) for antiRON4 antibody and Dr. Eizo Takashima (Ehime University, Japan) for
anti-Rh5 antibody. For rPM X production, the codon-engineered PM
X gene and protocols were provided by Don Lorimer (UCB Pharma).
We also thank Barb Vaupel for assistance with cloning, Dr. Darya

13

Article

https://doi.org/10.1038/s41467-022-32271-7

Urusova (WUSTL) for gel ﬁltration assays, Dr. Eva Istvan, Dr. Sebastian Nasamu and Dr. Alexander Polino for useful suggestions.

Reprints and permission information is available at
http://www.nature.com/reprints

Author contributions

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional afﬁliations.

S.M. and D.E.G. conceived and designed the study. S.M. performed
research, acquired, and analyzed data. S.N. and E.S. acquired data. S.M.
and D.E.G. wrote the manuscript.

Competing interests
All authors declare no competing interests.

Additional information
Supplementary information The online version contains supplementary
material available at
https://doi.org/10.1038/s41467-022-32271-7.
Correspondence and requests for materials should be addressed to
Daniel E. Goldberg.
Peer review information Nature Communications thanks Justin Boddey
and the other, anonymous, reviewer(s) for their contribution to the peer
review of this work. Peer reviewer reports are available.

Nature Communications | (2022)13:4537

Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as
long as you give appropriate credit to the original author(s) and the
source, provide a link to the Creative Commons license, and indicate if
changes were made. The images or other third party material in this
article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not
included in the article’s Creative Commons license and your intended
use is not permitted by statutory regulation or exceeds the permitted
use, you will need to obtain permission directly from the copyright
holder. To view a copy of this license, visit http://creativecommons.org/
licenses/by/4.0/.
© The Author(s) 2022

14

